BIAF
bioAffinity Technologies, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website bioaffinitytech.com
- Employees(FY) 14
- ISIN US09076W1099
Performance
+11.88%
1W
-20.14%
1M
+48.68%
3M
+58.04%
6M
+53.69%
YTD
+25.56%
1Y
Profile
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.
Technical Analysis of BIAF 2024-05-10
Overview:
In the last 5 trading days, BIAF stock has shown a downward trend in its price, with decreasing closing prices and declining volume. The trend indicators, momentum indicators, volatility indicators, and volume indicators all point towards a bearish sentiment in the stock.
Trend Indicators:
- The moving averages (MA) such as the 5-day MA...
Recent News & Updates
- 2024-05-15 09:55
- 2024-05-14 21:15
- 2024-05-01 20:00
bioAffinity Technologies News Update(Businesswire)
- 2024-04-23 20:00
- 2024-04-08 20:00
- 2024-04-01 10:53
- 2024-03-31 21:49
- 2024-03-08 00:15
- 2024-03-07 23:45
- 2024-03-05 21:45
- 2024-03-05 20:46
- 2024-03-04 19:00
- 2024-02-20 19:00
bioAffinity Technologies News Update(Businesswire)
- 2024-02-05 19:00
- 2024-01-29 19:00
bioAffinity Technologies In The News(Businesswire)
- 2024-01-22 19:00
- 2024-01-07 19:00
bioAffinity Technologies In the News(Businesswire)
- 2024-01-04 20:00
- 2023-12-04 19:00
- 2023-11-29 19:00
- 2023-11-27 19:00
- 2023-11-14 19:00
- 2023-11-14 03:01
- 2023-11-05 19:00
- 2023-10-09 20:00
- 2023-09-20 21:35
- 2023-09-18 20:00
- 2023-09-06 20:00
- 2023-08-14 05:03
- 2023-07-11 20:00
Page 1 of 2
previousnext